Cargando…

Lafutidine, a Protective H(2) Receptor Antagonist, Enhances Mucosal Defense in Rat Esophagus

BACKGROUND: Luminal acid or CO(2) induces a hyperemic response in the esophagus, via activation of acid sensors on capsaicin-sensitive afferent nerves (CSAN). Since disruption of the hyperemic response to luminal CO(2) acidifies the interstitium of the esophageal mucosa, the hyperemic response may m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akiba, Yasutada, Kaunitz, Jonathan D.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958262/ https://www.ncbi.nlm.nih.gov/pubmed/20824506 http://dx.doi.org/10.1007/s10620-010-1379-y

Ejemplares similares

Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values
por: Iida, Hiroshi, et al.
Publicado: (2009)

Mechanisms of Intragastric pH Sensing
por: Goo, Tyralee, et al.
Publicado: (2010)

Lubiprostone Stimulates Duodenal Bicarbonate Secretion in Rats
por: Mizumori, Misa, et al.
Publicado: (2009)

The protective effects of lafutidine for bortezomib induced peripheral neuropathy
por: Tsukaguchi, Machiko, et al.
Publicado: (2013)

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system
por: Iwasaki, Mari, et al.
Publicado: (2019)

Afferent signalling from the acid-challenged rat stomach is inhibited and gastric acid elimination is enhanced by lafutidine
por: Edelsbrunner, Martin E, et al.
Publicado: (2009)

Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia
por: Maity, Somnath, et al.
Publicado: (2014)

Application of UV spectrophotometric method for easy and rapid estimation of lafutidine in bulk and pharmaceutical formulation
por: Jadhav, Kiran, et al.
Publicado: (2011)

Excess iodine exposure acutely increases salivary iodide and antimicrobial hypoiodous acid concentrations in humans
por: Akiba, Yasutada, et al.
Publicado: (2022)

Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration
por: Fujiwara, Kaori, et al.
Publicado: (2015)

Whole Genome Expression Array Profiling Highlights Differences in Mucosal Defense Genes in Barrett's Esophagus and Esophageal Adenocarcinoma
por: Nancarrow, Derek J., et al.
Publicado: (2011)

No Long-Term Mucosal Lesions in the Esophagus but More Gastric Mucosal Lesions after Sleeve Gastrectomy in Obese Rats
por: Coupaye, Muriel, et al.
Publicado: (2023)

Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial
por: Dewan, Bhupesh, et al.
Publicado: (2011)

Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
por: Pinkerton, JoAnn V, et al.
Publicado: (2023)

Antibodies and Their Receptors: Different Potential Roles in Mucosal Defense
por: Horton, Rachel E., et al.
Publicado: (2013)

Intestinal Epithelial Inactivity of Dual Oxidase 2 Results in Microbiome-Mediated Metabolic Syndrome
por: Hazime, Hajar, et al.
Publicado: (2023)

Huge Lymphangioma of the Esophagus Resected by Endoscopic Piecemeal Mucosal Resection
por: Luo, Dinghai, et al.
Publicado: (2017)

Extraosseous Calcification of the Esophagus: Clinicopathologic Correlates of Esophageal Mucosal Calcinosis
por: Garber, Ari, et al.
Publicado: (2017)

Current Status of Mucosal Imaging with Narrow-Band Imaging in the Esophagus
por: Chiam, Keng Hoong, et al.
Publicado: (2021)

Underwater endoscopic mucosal resection for a protruding lesion in the esophagus
por: Doumbe-Mandengue, Paul, et al.
Publicado: (2022)

Iodine contrast exposure and incident COVID-19 infection
por: Tsai, Karen, et al.
Publicado: (2022)

Diagnostic Accuracy of Mucosal Biopsy versus Endoscopic Mucosal Resection in Barrett's Esophagus and Related Superficial Lesions
por: Elsadek, Hany M., et al.
Publicado: (2015)

The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
por: ZHAO, JUAN, et al.
Publicado: (2013)

Long-term results of the mucosal ablation of Barrett's esophagus: efficacy and recurrence
por: Saligram, Shreyas, et al.
Publicado: (2015)

The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage
por: Tuskey, Anne, et al.
Publicado: (2013)

Pancreatic glycoprotein 2 is a first line of defense for mucosal protection in intestinal inflammation
por: Kurashima, Yosuke, et al.
Publicado: (2021)

NK Cells in Mucosal Defense against Infection
por: Ivanova, Daria, et al.
Publicado: (2014)

Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense
por: Valenti, Piera, et al.
Publicado: (2018)

Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
por: Gyires, Klára, et al.
Publicado: (2016)

A Selective Histamine H(4) Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia
por: Dettori, Ilaria, et al.
Publicado: (2018)

RISK OF PRENEOPLASTIC LESIONS IN MUCOSAL PROJECTIONS OF DIFFERENT SIZES OF THE COLUMNAR EPITHELIUM IN THE LOWER ESOPHAGUS
por: Copetti, Hairton, et al.
Publicado: (2022)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
por: Komaki, Alireza, et al.
Publicado: (2014)

Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M
por: Rothschild, Daniel E., et al.
Publicado: (2016)

Effects of the Histamine H2 Receptor Antagonist Famotidine on the Healing of Colonic Anastomosis in Rats
por: İnan, Aydın, et al.
Publicado: (2009)

The protective effects of rosmarinic acid on ethanol-induced gastritis in male rats: antioxidant defense enhancement
por: Heidari, Fatemeh, et al.
Publicado: (2021)

Histamine H(1) receptor antagonists enhance the efficacy of antibacterials against Escherichia coli
por: Bruer, G. G., et al.
Publicado: (2019)

Use and Abuse of H(2) Receptor Antagonists
por: Hunt, Richard H.
Publicado: (1982)

Use and Abuse of H(2) Receptor Antagonists
Publicado: (1982)

TIPE polarity proteins are required for mucosal deployment of T lymphocytes and mucosal defense against bacterial infection
por: Li, Mingyue, et al.
Publicado: (2021)

In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii
por: Ricci, Susanna, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_8rb2d4mhmvg7pqkeml46t9dium